18 July 2018 - Deborah Wilkes
Archived
Draft guidance from the US Food and Drug Administration (FDA) paves the way for companies switching medicines from prescription to non-prescription status to make use of new types of labelling and digital health technologies.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.